Ki-67与术前皮质醇功能减退是内镜垂体瘤切除术后尿崩症的预测因素
该研究纳入141例2019至2023年接受内镜垂体瘤手术的患者,按术后是否发生尿崩症分组分析危险因素。结果显示67例(47.5%)术后发生尿崩症,多为暂时性;术前肾上腺功能不全(OR 4.22,95%CI 1.15-15.51,P=0.030)与Ki-67≥3%(OR 3.04,95%CI 1.17-7.85,P=0.022)独立增加尿崩症风险。结论提示对术前肾上腺功能不全或Ki-67≥3%的患者术后应密切监测液体平衡,并及时使用去氨加压素管理尿崩症。
要点
- 术前肾上腺功能不全独立增加术后尿崩症风险(OR 4.22,P=0.030)。
- Ki-67≥3%独立增加术后尿崩症风险(OR 3.04,P=0.022)。
- 术后尿崩症发生率为47.5%,多为暂时性,需密切监测液体平衡。
核心结论
- 术前肾上腺功能不全或Ki-67≥3%的患者内镜垂体瘤切除术后更易发生尿崩症。
- 术后密切监测液体平衡并及时使用去氨加压素有助于有效管理尿崩症。
研究设计与样本
- 回顾性研究纳入141例2019至2023年接受内镜垂体瘤手术的患者,按术后是否发生尿崩症分组。
- 采用统计学分析识别术后尿崩症的危险因素。
主要发现
- 67例(47.5%)患者术后发生尿崩症,多为暂时性。
- 术前肾上腺功能不全的OR为4.22(95%CI 1.15-15.51,P=0.030)。
- Ki-67≥3%的OR为3.04(95%CI 1.17-7.85,P=0.022)。
关键数值与推荐
- 术前肾上腺功能不全:OR 4.22,95%CI 1.15-15.51,P=0.030。
- Ki-67≥3%:OR 3.04,95%CI 1.17-7.85,P=0.022。
临床怎么用
- 对术前肾上腺功能不全或Ki-67≥3%的患者,术后应密切监测液体平衡。
- 术后出现尿崩症时应及时使用去氨加压素进行管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diabetes insipidus (DI) frequently occurs after surgery to remove pituitary tumors. It prolongs hospital stays, increases costs, and raises risks of other health issues. This study aims to identify risk factors for DI after pituitary tumor surgery to aid in early identification of high-risk patients. METHODS: We studied 141 patients who had endoscopic pituitary tumor surgery from 2019 to 2023. Patients were grouped based on whether they developed DI postsurgery. We used statistical analyses to identify risk factors. RESULTS: Among the patients, 67 (47.5%) developed DI postsurgery, mostly transient. Factors like preoperative adrenal insufficiency (odds ratio 4.22, 95% confidence interval 1.15-15.51, P = 0.030) and Ki-67≥3% (odds ratio 3.04, 95% CI 1.17-7.85, P = 0.022) were found to independently increase DI risk. CONCLUSION: Patients with preoperative adrenal insufficiency or Ki-67≥3% are more likely to develop DI after surgery. Close monitoring of fluid balance is crucial post-surgery, and prompt use of desmopressin can help manage DI effectively.
引用
- Li G, Li M, Xie B, et al. Ki-67 and Preoperative Hypocortisolism are Predictive Factors for Postoperative Diabetes Insipidus After Endoscopic Pituitary Tumor Resection. World Neurosurg. 2025. PMID: 41319733. doi:10.1016/j.wneu.2025.124692
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。